Cash & equivalents decreased 26.9%
Cash & equivalents changed -26.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -26.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross profit changed -55.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Inventory changed -70.1% from the comparable as-filed period.
Operating margin changed -287071 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed +36.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed -53.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed +31.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross margin changed -188 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Net income changed -15.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating income changed -15.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.